Please provide your email address to receive an email when new articles are posted on . The wastage cost represents a mean 1.78% of the total cost of treatment. Researchers suggested further study of ...
Hosted on MSN
FDA and EMA review Biogen's higher dose SMA drug
CAMBRIDGE, Mass. - Biogen Inc. (NASDAQ:BIIB), a $20.8 billion biotechnology company with a robust 75.6% gross profit margin, has reached a pivotal phase as regulatory agencies in the United States and ...
Spinraza (nusinersen) is a brand-name drug that’s prescribed for spinal muscular atrophy (SMA) in adults and children. Spinraza comes as a spinal injection that’s given by a healthcare professional ...
The new approval allows for the 2000mg loading dose to be administered as an IV push rather than a 30-minute IV infusion. The prescribing information for Trogarzo ® (ibalizumab-uiyk) has been updated ...
Cyltezo (adalimumab-adbm) is a brand-name drug prescribed for several inflammatory conditions. Cyltezo comes as a liquid solution given by subcutaneous injection. It’s available as a single-dose ...
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both treatment-naïve and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results